MedPath
FDA Approval

TERBINAFINE HYDROCHLORIDE

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Cipla USA Inc.
DUNS: 078719707
Effective Date
January 5, 2021
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Terbinafine(250 mg in 1 1)

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

TERBINAFINE HYDROCHLORIDE

Product Details

NDC Product Code
69097-731
Application Number
ANDA077137
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
January 5, 2021
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
Code: 012C11ZU6GClass: ACTIBQuantity: 250 mg in 1 1
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2Class: IACT
© Copyright 2025. All Rights Reserved by MedPath